Aug 09, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Suven Pharmaceuticals Limited Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Ms. Cyndrella Carvalho from Suven Pharmaceuticals Limited. Thank you and over to you, ma'am.
Cyndrella Carvalho - Suven Pharmaceuticals Ltd - Head of Investor Relations
Thanks, Darwin. Good evening, everyone. We welcome you all on our quarter one FY25 earnings conference call. Let me introduce you to our management team here. Mr. Annaswamy Vaidheesh, Executive Chairman; Dr. Prasada Raju, Managing Director; Dr. Sudhir Kumar Singh, CEO; and Mr. Himanshu Agarwal, our CFO. After our opening remarks, we will open the floor for Q&A.
Now, I hand over the call to our Managing Director, Dr. Prasada for his opening remarks. Over to you, sir.
Vetukuri Venkata Prasada Raju - Suven Pharmaceuticals Ltd - Managing Director, Executive Director
Thank you, Cyndrella. A very good evening to
Q1 2025 Suven Pharmaceuticals Ltd Earnings Call Transcript
Aug 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers